Visionary teams
Founders who channel domain expertise into ambitious product development.
Formerly Fortech Ventures · Romania & CEE
Nucleo Ventures backs early-stage teams that combine corporate experience, engineering excellence and deep market insight to build product-led companies that can disrupt traditional industries.
Investment thesis
We invest in founders who understand real industry pain because they have lived it from inside corporations, engineering teams and complex enterprise environments.
Our role is to help them move faster from concept to market-ready product, then from early traction to scalable go-to-market, follow-on financing and strategic exit optionality.
Founders who channel domain expertise into ambitious product development.
Teams that combine industry insight with technical depth and execution discipline.
Support for market validation, customer access, hiring, follow-on rounds and exits.
A bridge for talent and companies moving from services to scalable software products.
Thematic focus
We look for globally relevant companies built from Romania and CEE, with strong technical moats and clear commercial urgency.
Digital adoption, clinical workflow innovation, diagnostics, treatment and health-data infrastructure.
Underserved industrial software, factory optimisation, visual CPQ and Industry 4.0 workflows.
Software for resilient, sustainable energy infrastructure serving B2B and B2G markets.
Core fintech, payments and banking infrastructure as financial services continue to reshape.
Dual-use software, cyber-resilience, secure infrastructure and mission-critical systems.
Why now
Romania remains underserved outside Bucharest, while universities, software agencies and global tech employers continue to create strong technical talent. Nucleo is built to convert that talent into globally ambitious companies.
Track record
Through the previous Fortech Investments vehicle, the team built a diversified technology portfolio across healthcare, energy, manufacturing, automotive, proptech and other sectors.
tech startups backed through the previous vehicle
invested in technology companies
reported IRR to date
reported current portfolio fair value
portfolio companies with board involvement
4× ARR growth from €500K to €2.3M and enterprise pharma/CRO customers.
Operating in 120 hospitals, analysing 50K+ images per month.
2.6× YoY revenue growth and €4.5M raised from climate-tech investors.
Founder-market fit
Complementary team dynamics
Significant pain-killer problem
Large market, typically €1B+
Well-timed technical innovation
Early proof of scalable traction
Clear exit pathways
What we look for
We evaluate founders, markets and products through a practical framework: urgency of the problem, depth of technical insight, commercial scalability, customer pull and credible strategic exit potential.
Team
The Nucleo team combines the perspectives founders need early: enterprise software, venture building, financial discipline, legal structuring, brand, AI and go-to-market support.
Product and engineering judgement for complex B2B environments.
Hands-on support from idea validation to scaling and follow-on rounds.
Fund, LP and financing experience for disciplined portfolio construction.
Transaction, restructuring and governance know-how for resilient companies.
Deep-tech pattern recognition and internal tools for faster investment work.
Content, ecosystem presence and network-building for founders and co-investors.
Open position
No fixed role in mind yet. We are looking for someone rigorous, curious and high-agency who can add leverage across investing, founder support, platform, operations or ecosystem building.
Investment process
We reduce analysis paralysis with a clear timeline, combining expert review, data-driven screening and hands-on technical diligence.
Problem, solution, market, team and funding needs.
Technical depth, workflows and product differentiation.
Full investment-team calibration and open questions.
Internal debrief within one week of the last call.
Market, competition, customer and partner validation.
Legal, financial, technical and ESG review over 3–4 weeks.
Finalize documentation and complete the investment.
Ongoing monitoring, support, follow-on and exit scouting.
Platform
We use in-house and third-party tools to screen faster, monitor better and unlock targeted introductions for founders.
Structured pitch-deck summaries for high-precision screening.
Q&A access to investment knowledge and portfolio insights.
Network mapping for highly targeted founder introductions.
KPI monitoring, forecasting and deal-status discipline.
Founders & co-investors
Send us your deck, a concise note about your company, or reach out if you want to help build Nucleo.